We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+8.69%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$6.79B
AUM Growth
-$19.8M
Cap. Flow
-$506M
Cap. Flow %
-7.46%
Top 10 Hldgs %
64.12%
Holding
139
New
17
Increased
28
Reduced
77
Closed
11

Top Buys

Rank Stock Value
1
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$17M
2
JNJ icon
Johnson & Johnson
JNJ
+$12.1M
3
SHPG
Shire pic
SHPG
+$8.78M
4
AGN
Allergan plc
AGN
+$5.04M
5
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
+$2.88M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$41.2M
2
HDB icon
HDFC Bank
HDB
+$38.7M
3
UNP icon
Union Pacific
UNP
+$29.7M
4
MSFT icon
Microsoft
MSFT
+$28.8M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$28.6M

Sector Composition

Rank Sector Weight
1 Financials 34.47%
2 Healthcare 19.26%
3 Communication Services 16.08%
4 Consumer Discretionary 11.63%
5 Industrials 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CPHD
51
DELISTED
Cepheid Inc
CPHD
$4.79M 0.07%
88,421
-31,579
-26% -$1.6M
SPNC
52
DELISTED
Spectranetics Corp
SPNC
$4.29M 0.06%
123,956
-53,314
-30% -$1.66M
ABMD
53
DELISTED
Abiomed Inc
ABMD
$3.99M 0.06%
104,888
-65,112
-38% -$2.05M
DXCM icon
54
DexCom
DXCM
$29.2B
$3.85M 0.06%
279,700
-120,300
-30% -$1.47M
ATHN
55
DELISTED
Athenahealth, Inc.
ATHN
$3.82M 0.06%
26,222
-11,278
-30% -$1.42M
NOC icon
56
Northrop Grumman
NOC
$77.2B
$3.46M 0.05%
23,500
– –
WCG
57
DELISTED
Wellcare Health Plans, Inc.
WCG
$3.44M 0.05%
41,955
-18,045
-30% -$1.26M
KYTH
58
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$3.26M 0.05%
94,017
-33,083
-26% -$1.15M
PODD icon
59
Insulet
PODD
$11.7B
$3.16M 0.05%
68,620
-115,320
-63% -$4.93M
TTPH
60
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$3.12M 0.05%
3,922
-1,078
-22% -$580K
ACAD icon
61
Acadia Pharmaceuticals
ACAD
$4.46B
$3.01M 0.04%
+94,925
New +$2.69M
NUVA
62
DELISTED
NuVasive, Inc.
NUVA
$2.98M 0.04%
63,160
-27,165
-30% -$1.13M
EXAM
63
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
$2.91M 0.04%
+69,925
New +$2.67M
MA icon
64
Mastercard
MA
$497B
$2.84M 0.04%
33,000
-8,000
-20% -$653K
SRNE
65
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$2.74M 0.04%
272,301
-97,699
-26% -$495K
MCK icon
66
McKesson
MCK
$106B
$2.69M 0.04%
12,940
+560
+5% +$114K
AERI
67
DELISTED
Aerie Pharmaceuticals
AERI
$2.65M 0.04%
90,903
-39,097
-30% -$991K
VRTX icon
68
Vertex Pharmaceuticals
VRTX
$124B
$2.6M 0.04%
21,900
-2,500
-10% -$282K
LO
69
DELISTED
LORILLARD INC COM STK
LO
$2.58M 0.04%
41,000
– –
LDRH
70
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
$2.52M 0.04%
76,917
-53,083
-41% -$1.74M
MD icon
71
Pediatrix Medical
MD
$2.18B
$2.31M 0.03%
34,962
-15,038
-30% -$918K
MDXG icon
72
MiMedx Group
MDXG
$645M
$2.31M 0.03%
+200,000
New +$1.98M
MASI
73
DELISTED
Masimo
MASI
$2.27M 0.03%
86,008
-36,992
-30% -$913K
TVRD
74
Tvardi Therapeutics
TVRD
$22.5M
$2.11M 0.03%
5,884
+290
+5% +$93.4K
KTWO
75
DELISTED
K2M Group Holdings, Inc
KTWO
$2.11M 0.03%
101,151
+1,151
+1% +$19.9K
1 2
3
4 5

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q4 2014 Portfolio in Review

As of Q4 2014, C WorldWide Group held 139 positions worth $6.79B, down 0.29% from $6.81B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

C WorldWide Group withdrew a net $506M in Q4 2014, closing 11 positions and reducing 77 holdings. Its most notable exit was AUXILIUM PHARAMCEUTICALS INC, an estimated $8.32M position sold in full.

By sector, the portfolio is most concentrated in Financials at 34% of assets, up from 33% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, C WorldWide Group opened a new position in AUSPEX PHARMACEUTICALS INC COM STK (DE) worth $5.14M.

  • C WorldWide Group's largest Q4 2014 buy was AUSPEX PHARMACEUTICALS INC COM STK (DE): 97,921 shares worth $5.14M.
  • C WorldWide Group added most to SALIX PHARMACEUTICALS LTD DEL in Q4 2014, an estimated $17M increase.
  • C WorldWide Group's biggest Q4 2014 reduction was Visa, cutting an estimated $41.2M.
  • C WorldWide Group fully exited AUXILIUM PHARAMCEUTICALS INC in Q4 2014, selling an estimated $8.32M.
  • C WorldWide Group's ten largest holdings make up 64% of its $6.79B portfolio in Q4 2014.
  • C WorldWide Group opened 17 new positions and closed 11 in Q4 2014.
  • C WorldWide Group's portfolio value fell 0.29% quarter-over-quarter to $6.79B.

Based on C WorldWide Group's 13F filing for Q4 2014, filed 11 Feb 2015.